Metformin changes the immune microenvironment of colorectal cancer in patients with type 2 diabetes mellitus
Accumulating evidence suggests that metformin reduces the incidence and mortality of colorectal cancer (CRC). However, underlying mechanisms have not been fully clarified. The aim of this study was to examine the pathological characteristics of resected CRC from patients treated with metformin for t...
Uložené v:
| Vydané v: | Cancer science Ročník 111; číslo 11; s. 4012 - 4020 |
|---|---|
| Hlavní autori: | , , , , , , , , , |
| Médium: | Journal Article |
| Jazyk: | English |
| Vydavateľské údaje: |
England
John Wiley & Sons, Inc
01.11.2020
John Wiley and Sons Inc |
| Predmet: | |
| ISSN: | 1347-9032, 1349-7006, 1349-7006 |
| On-line prístup: | Získať plný text |
| Tagy: |
Pridať tag
Žiadne tagy, Buďte prvý, kto otaguje tento záznam!
|
Buďte prvý, kto okomentuje tento záznam!